Evotec is participating in the €8 million ($8.46 million) Series A of its current partner in developing metabolic disease therapy Eternygen.

Aptuit, a CRO focused on early to mid-phase drug development, has inked a deal with Chiesi Farmaceutici to develop new drugs for idiopathic pulmonary fibrosis.

A joint working group is trying to remove obstacles to clinical research in India.

Intec Pharma has again tapped the Michael J. Fox Foundation for Parkinson’s Research for development of its Parkinson’s med AP-CD/LD.

CROs can look forward to “steady but tentative growth” in the coming years, but the biggest gainers will be the largest companies in the business, with the…

As both healthcare data and consultancy firm IMS Health and Quintiles, the world’s largest CRO, begin the process of becoming one giant $19 billion entity, the…

Clinical study provider Biomedical Systems has formed a new collab with digital health company Foundry to be able to help pharma, biotech and CRO clients view…

Increasingly acquisitive Charles River Laboratories has signed a new pact with the Milner Therapeutics Institute and Consortium that will see it become the…

Partnering